Natural and synthetic GHSR1a agonists as neuroprotective agents in models of Parkinson's disease
Parkinson’s disease (PD) is the second most prevalent neurodegenerative disorder in humans. It is characterised by the progressive loss of the A9 (Girk2+) subpopulation of dopamine (DA) neurones in the Substantia Nigra Pars Compacta (SNpc) resulting in resting tremor, bradykinesia and rigidity. The...
| Main Author: | |
|---|---|
| Other Authors: | |
| Published: |
Swansea University
2017
|
| Online Access: | https://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.752373 |